Abdel-Bary, N., Hashem, T., Metwali, H., Abd el Ghany, A., Magied, H., & El-Herbeiny, M. (2009). Phase II study of ‘high-dose’ celecoxib and metronomic ‘low-dose’ cyclophosphamide and methotrexate in patients with relapsed and refractory lymphoma. Cancer Intelligence.
Citação norma ChicagoAbdel-Bary, N., T. Hashem, H. Metwali, A. Abd el Ghany, HA Magied, and M. El-Herbeiny. Phase II Study of ‘high-dose’ Celecoxib and Metronomic ‘low-dose’ Cyclophosphamide and Methotrexate in Patients With Relapsed and Refractory Lymphoma. Cancer Intelligence, 2009.
Citação norma MLAAbdel-Bary, N., et al. Phase II Study of ‘high-dose’ Celecoxib and Metronomic ‘low-dose’ Cyclophosphamide and Methotrexate in Patients With Relapsed and Refractory Lymphoma. Cancer Intelligence, 2009.